154 related articles for article (PubMed ID: 27596217)
21. The impact of central review and central therapy planning on the treatment of children and adolescents with Hodgkin lymphoma.
Lüders H; Rühl U; Marciniak H; Haerting J; Claviez A; Mann G; Schellong G; Wickmann L; Dörffel W
Eur J Cancer; 2014 Jan; 50(2):425-33. PubMed ID: 24157256
[TBL] [Abstract][Full Text] [Related]
22. Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.
Sasse S; Bröckelmann PJ; Goergen H; Plütschow A; Müller H; Kreissl S; Buerkle C; Borchmann S; Fuchs M; Borchmann P; Diehl V; Engert A
J Clin Oncol; 2017 Jun; 35(18):1999-2007. PubMed ID: 28418763
[TBL] [Abstract][Full Text] [Related]
23. Patient-related quality assurance with different combinations of treatment planning systems, techniques, and machines : A multi-institutional survey.
Steiniger B; Berger R; Eilzer S; Kornhuber C; Lorenz K; Peil T; Reiffenstuhl C; Schilz J; Schröder D; Schwedas M; Pensold S; Walke M; Weibert K; Wolf U; Wiezorek T
Strahlenther Onkol; 2017 Jan; 193(1):46-54. PubMed ID: 27812732
[TBL] [Abstract][Full Text] [Related]
24. Radiotherapy quality assurance report from children's oncology group AHOD0031.
Dharmarajan KV; Friedman DL; FitzGerald TJ; McCarten KM; Constine LS; Chen L; Kessel SK; Iandoli M; Laurie F; Schwartz CL; Wolden SL
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1065-71. PubMed ID: 25670539
[TBL] [Abstract][Full Text] [Related]
25. Radiotherapy for Prostate Cancer: is it 'what you do' or 'the way that you do it'? A UK Perspective on Technique and Quality Assurance.
Mason MD; Moore R; Jones G; Lewis G; Donovan JL; Neal DE; Hamdy FC; Lane JA; Staffurth JN;
Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e92-e100. PubMed ID: 27425582
[TBL] [Abstract][Full Text] [Related]
26. Involved Site Radiotherapy Extends Time to Premature Menopause in Infra-Diaphragmatic Female Hodgkin Lymphoma Patients - An Analysis of GHSG HD14- and HD17-Patients.
Rosenbrock J; Vásquez-Torres A; Mueller H; Behringer K; Zerth M; Celik E; Fan J; Trommer M; Linde P; Fuchs M; Borchmann P; Engert A; Marnitz S; Baues C
Front Oncol; 2021; 11():658358. PubMed ID: 34113567
[TBL] [Abstract][Full Text] [Related]
27. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines.
Girinsky T; van der Maazen R; Specht L; Aleman B; Poortmans P; Lievens Y; Meijnders P; Ghalibafian M; Meerwaldt J; Noordijk E
Radiother Oncol; 2006 Jun; 79(3):270-7. PubMed ID: 16797755
[TBL] [Abstract][Full Text] [Related]
28. Processes for quality improvements in radiation oncology clinical trials.
FitzGerald TJ; Urie M; Ulin K; Laurie F; Yorty J; Hanusik R; Kessel S; Jodoin MB; Osagie G; Cicchetti MG; Pieters R; McCarten K; Rosen N
Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S76-9. PubMed ID: 18406943
[TBL] [Abstract][Full Text] [Related]
29. Breath-hold technique in conventional APPA or intensity-modulated radiotherapy for Hodgkin's lymphoma: Comparison of ILROG IS-RT and the GHSG IF-RT.
Kriz J; Spickermann M; Lehrich P; Schmidberger H; Reinartz G; Eich H; Haverkamp U
Strahlenther Onkol; 2015 Sep; 191(9):717-25. PubMed ID: 25876905
[TBL] [Abstract][Full Text] [Related]
30. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
[TBL] [Abstract][Full Text] [Related]
31. Initial experience with the quality assurance program of radiation therapy on behalf of Japan Radiation Oncology Group (JAROG).
Isobe K; Kagami Y; Higuchi K; Kodaira T; Hasegawa M; Shikama N; Nakazawa M; Fukuda I; Nihei K; Ito K; Teshima T; Oguchi M;
Jpn J Clin Oncol; 2007 Feb; 37(2):135-9. PubMed ID: 17255160
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Hodgkin's disease: results and current concepts of the German Hodgkin's Lymphoma Study Group.
Sieber M; Engert A; Diehl V
Ann Oncol; 2000; 11 Suppl 1():81-5. PubMed ID: 10707785
[TBL] [Abstract][Full Text] [Related]
33. Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group.
Kriz J; Reinartz G; Dietlein M; Kobe C; Kuhnert G; Haverkamp H; Haverkamp U; Engenhart-Cabillic R; Herfarth K; Lukas P; Schmidberger H; Staar S; Hegerfeld K; Baues C; Engert A; Eich HT
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):46-53. PubMed ID: 25863753
[TBL] [Abstract][Full Text] [Related]
34. Dummy run of quality assurance program in a phase 3 randomized trial investigating the role of internal mammary lymph node irradiation in breast cancer patients: Korean Radiation Oncology Group 08-06 study.
Chung Y; Kim JW; Shin KH; Kim SS; Ahn SJ; Park W; Lee HS; Kim DW; Lee KC; Suh HS; Kim JH; Shin HS; Kim YB; Suh CO
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):419-26. PubMed ID: 25636764
[TBL] [Abstract][Full Text] [Related]
35. [A teleradiotherapeutic network for lymphoma patients within the competence network malignant lymphomas].
Eich HT; Schneeweiss A; Skripnitchenko R; Hansemann K; Gossmann A; Müller RP
Rontgenpraxis; 2007; 56(4):145-51. PubMed ID: 17390954
[TBL] [Abstract][Full Text] [Related]
36. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT).
Hartford AC; Palisca MG; Eichler TJ; Beyer DC; Devineni VR; Ibbott GS; Kavanagh B; Kent JS; Rosenthal SA; Schultz CJ; Tripuraneni P; Gaspar LE; ;
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):9-14. PubMed ID: 19100920
[No Abstract] [Full Text] [Related]
37. Radiation doses to mediastinal organs at risk in early-stage unfavorable Hodgkin lymphoma- a risk stratified analysis of the GHSG HD17 trial.
Oertel M; Hering D; Baues C; Kittel C; Fuchs M; Kriz J; Kröger K; Vordermark D; Herfarth K; Engenhart-Cabillic R; Lukas P; Haverkamp U; Borchmann P; Eich HT
Front Oncol; 2023; 13():1183906. PubMed ID: 37213291
[TBL] [Abstract][Full Text] [Related]
38. Results of a quality assurance review of external beam radiation therapy in the International Society of Paediatric Oncology (Europe) Neuroblastoma Group's High-risk Neuroblastoma Trial: a SIOPEN study.
Gaze MN; Boterberg T; Dieckmann K; Hörmann M; Gains JE; Sullivan KP; Ladenstein R
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):170-4. PubMed ID: 22749633
[TBL] [Abstract][Full Text] [Related]
39. Accrediting radiation technique in a multicentre trial of chemoradiation for pancreatic cancer.
Spry N; Bydder S; Harvey J; Borg M; Ngan S; Millar J; Graham P; Zissiadis Y; Kneebone A; Ebert M
J Med Imaging Radiat Oncol; 2008 Dec; 52(6):598-604. PubMed ID: 19178636
[TBL] [Abstract][Full Text] [Related]
40. Optimizing Radiation Therapy Quality Assurance in Clinical Trials: A TROG 08.03 RAVES Substudy.
Trada Y; Kneebone A; Paneghel A; Pearse M; Sidhom M; Tang C; Wiltshire K; Haworth A; Fraser-Browne C; Martin J
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1045-51. PubMed ID: 26475066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
